skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

A synthetic lethal drug combination mimics glucose deprivation–induced cancer cell death in the presence of glucose

The Journal of biological chemistry, 2020-01, Vol.295 (5), p.1350-1365 [Peer Reviewed Journal]

2020 Joly et al. 2020 Joly et al. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.RA119.011471 ;PMID: 31914417

Full text available

Citations Cited by
  • Title:
    A synthetic lethal drug combination mimics glucose deprivation–induced cancer cell death in the presence of glucose
  • Author: Joly, James H. ; Delfarah, Alireza ; Phung, Philip S. ; Parrish, Sydney ; Graham, Nicholas A.
  • Subjects: Metabolism
  • Is Part Of: The Journal of biological chemistry, 2020-01, Vol.295 (5), p.1350-1365
  • Description: Metabolic reprogramming in cancer cells can increase their dependence on metabolic substrates such as glucose. As such, the vulnerability of cancer cells to glucose deprivation creates an attractive opportunity for therapeutic intervention. Because it is not possible to starve tumors of glucose in vivo , here we sought to identify the mechanisms in glucose deprivation–induced cancer cell death and then designed inhibitor combinations to mimic glucose deprivation–induced cell death. Using metabolomic profiling, we found that cells undergoing glucose deprivation–induced cell death exhibited dramatic accumulation of intracellular l -cysteine and its oxidized dimer, l -cystine, and depletion of the antioxidant GSH. Building on this observation, we show that glucose deprivation–induced cell death is driven not by the lack of glucose, but rather by l -cystine import. Following glucose deprivation, the import of l -cystine and its subsequent reduction to l -cysteine depleted both NADPH and GSH pools, thereby allowing toxic accumulation of reactive oxygen species. Consistent with this model, we found that the glutamate/cystine antiporter (xCT) is required for increased sensitivity to glucose deprivation. We searched for glycolytic enzymes whose expression is essential for the survival of cancer cells with high xCT expression and identified glucose transporter type 1 (GLUT1). Testing a drug combination that co-targeted GLUT1 and GSH synthesis, we found that this combination induces synthetic lethal cell death in high xCT-expressing cell lines susceptible to glucose deprivation. These results indicate that co-targeting GLUT1 and GSH synthesis may offer a potential therapeutic approach for targeting tumors dependent on glucose for survival.
  • Publisher: 11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A: American Society for Biochemistry and Molecular Biology
  • Language: English
  • Identifier: ISSN: 0021-9258
    EISSN: 1083-351X
    DOI: 10.1074/jbc.RA119.011471
    PMID: 31914417
  • Source: PubMed Central
    Alma/SFX Local Collection

Searching Remote Databases, Please Wait